InvestorsHub Logo
Followers 59
Posts 3743
Boards Moderated 0
Alias Born 05/25/2021

Re: skitahoe post# 692183

Thursday, 05/16/2024 10:09:40 PM

Thursday, May 16, 2024 10:09:40 PM

Post# of 695357
Gary,

For other types of cancer, the number of patients through compassionate use program is only in tens. The number is not enough for filling for approval. My conjecture is the application should be at minimum DCVax-L combined with Poly-ICLC with possible guidance from RA about including keytruda. IMO, the approval will be based on the RWE from compassionate use patients.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News